Table 2 Clinical course, age and gender distribution of the studied CLN3 patients who did not receive anticonvulsants.
From: Analysis of Potential Biomarkers and Modifier Genes Affecting the Clinical Course of CLN3 Disease
Clinical course | Patient | Age (years) | Gender | Index of Relative Severity |
|---|---|---|---|---|
Rapid | 1 | 12 | F | −1.4 |
2a | 12 | F | −0.8 | |
Slow | 3 | 29 | M | 1.2 |
4 | 28 | M | 0.8 | |
Average | 5a | 18 | F | −0.1 |
6b | 10 | M | 0 | |
7b | 9 | F | −0.3 | |
8 | 12 | M | −0.3 |